QTRX
QTRX
NASDAQ · Life Sciences Tools & Services

Quanterix Corp

$2.78
+0.01 (+0.36%)
As of May 16, 2:00 AM ET ·
Financial Highlights (FY 2026)
Revenue
152.90M
Net Income
-117,951,513
Gross Margin
46.8%
Profit Margin
-77.1%
Rev Growth
+9.6%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 46.8% 46.8% 49.1% 49.1%
Operating Margin -90.4% -81.3% 5.5% 6.4%
Profit Margin -77.1% -73.3% 6.1% 4.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 152.90M 139.50M 208.12M 186.61M
Gross Profit 71.51M 65.25M 102.12M 91.57M
Operating Income -138,187,191 -113,474,883 11.39M 11.88M
Net Income -117,951,513 -96,857,994 12.69M 8.67M
Gross Margin 46.8% 46.8% 49.1% 49.1%
Operating Margin -90.4% -81.3% 5.5% 6.4%
Profit Margin -77.1% -73.3% 6.1% 4.6%
Rev Growth +9.6% +9.6% +19.2% -2.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 136.63M 133.70M
Total Equity 229.88M 201.96M
D/E Ratio 0.59 0.66
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -115,576,525 -100,180,382 15.93M 14.55M
Free Cash Flow 9.96M 8.22M